Biostage, Inc.
BSTG · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $58 | $53 | $62 | $23 |
| - Cash | $2 | $0 | $1 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $56 | $53 | $61 | $22 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$8 | -$9 | -$6 | -$9 |
| % Margin | – | – | – | – |
| Net Income | -$8 | -$9 | -$6 | -$8 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.52 | -0.67 | -1.09 | -0.74 |
| % Growth | 22.4% | 38.5% | -47.3% | – |
| Operating Cash Flow | -$5 | -$7 | -$5 | -$3 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$5 | -$7 | -$5 | -$3 |